|
|
Demonstrated to be Safe
Clinical trials have proven the safety of NeuroStar TMS Therapy in treating patients
who have had an inadequate response to prior antidepressant medications.
Treatment with NeuroStar TMS Therapy caused very few side effects and was generally
well tolerated by patients. The most common side effect reported during clinical
trials was scalp pain or discomfort—generally mild to moderate and occurring less
frequently after the first week of treatment.
Less than 5% of patients discontinued treatment with NeuroStar TMS Therapy due to
adverse events.
Over 10,000 active treatments safely performed across all NeuroStar® clinical trials1
- No seizures
- No systemic side effects
- No weight gain
- No sexual dysfunction
- No sedation
- No nausea
- No dry mouth
- No adverse effects on concentration or memory
- No device-drug interactions
NeuroStar TMS Therapy is contraindicated in patients with implanted metallic
devices or non-removable metallic objects in or around the head. NeuroStar TMS
Therapy should not be used in patients with implants controlled by physiological
signals. This includes pacemakers, implantable cardioverter defibrillators (ICDs),
and vagus nerve stimulators (VNS).
References:
- Janicak, P, et al. Transcranial Magnetic Stimulation (TMS) in the Treatment
of Major Depression: A Comprehensive Summary of Safety Experience from Acute
Exposure, Extended Exposure and During Reintroduction Treatment. Journal of
Clinical Psychiatry, February 2008.
|
|
 |
|
Refer a Patient for Treatment
|
NeuroStar TMS Therapy may be right for your patients suffering from major depression. Refer them here.
Find a Provider
|
|
|
|
Become a NeuroStar TMS Therapy Provider
|
Provide your patients the new way back from depression with NeuroStar TMS Therapy®.
Contact us to find out how you can bring NeuroStar into your workplace.
Contact Us
|
|
|
*
NeuroStar TMS Therapy® is indicated for the treatment of Major Depressive
Disorder in adult patients who have failed to achieve satisfactory improvement from
one prior antidepressant medication at or above the minimal effective dose and duration
in the current episode.
|